Kidney cancer. Principles and practice. Second edition. Primo N. Lara, Jr. Eric Jonasch (Editors). Springer International Publishing (2015)

  1. Chow WH, Devesa SS, Warren JL et al (1999) Rising incidence of renal cell cancer in the United States. JAMA 281:1628–1631
  2. Hollingsworth JM, Miller DC, Daignault S et al (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98: 1331–1334
  3. American Cancer Society (2014) Cancer facts and figures 2014. American Cancer Society, Atlanta
  4. Motzer RJ, Jonasch E, Agarwal N et al (2014) NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw 12:175–182
  5. Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279
  6. Parsons JK, Schoenberg MS, Carter HB (2001) Incidental renal tumors: casting doubt on the efficacy of early intervention. Urology 57:1013–1015
  7. Mckiernan J, Yossepowitch O, Kattan MW et al (2002) Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. Urology 60:1003–1009
  8. Kutikov A, Fossett LK, Ramchandani P et al (2006) Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology 68:737–740
  9. Lane BR, Poggio ED, Herts BR et al (2009) Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol 182:435–443; discussion 443–444
  10. Lane BR, Demirjian S, Weight CJ et al (2010) Performance of the chronic kidney disease-epidemiology study equations for estimating glomerular filtration rate before and after nephrectomy. J Urol 183:896–901
  11. Canter D, Kutikov A, Sirohi M et al (2011) Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors. Urology 77:781–785
  12. Frank I, Blute ML, Cheville JC et al (2003) Solid renal tumors: an analysis of pathologic features related to tumor size. J Urol 170:2217–2220
  13. Volpe A, Gill IS, Uzzo RG et al (2012) Rationale for percutaneous biopsy and histologic characterisation of renal tumors. Eur Urol 62:505–506
  14. Chawla SN, Crispen PL, Hanlon AL et al (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175:425–431
  15. Kinsella K, Velkoff VA (2001) An aging world [series py5/O1-1]. U.S. Census Bureau (Government Printing Office), Washington, DC
  16. Yancik R, Ries LA (2004) Cancer in older persons: an international issue in an aging world. Semin Oncol 31:128–136
  17. Piccirillo JF, Tierney RM, Costas I et al (2004) Prognostic importance of comorbidity in a hospitalbased cancer registry. JAMA 291:2441–2447
  18. de Groot V, Beckerman H, Lankhorst GJ et al (2003) How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 56:221–229
  19. Rozzini R, Sabatini T, Barbisoni P et al (2004) How to measure comorbidity in elderly persons. J Clin Epidemiol 57:321–322
  20. Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
  21. Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156
  22. Revening LM, Canter DJ, Taylor MD et al (2013) Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes. J Am Coll Surg 217:665–670
  23. Hanrahan EO, Gonzalez-Angulo AM, Giordano SH et al (2007) Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast carcinoma. J Clin Oncol 25:4952–4960
  24. Mell LK, Dignam JJ, Salama JK et al (2010) Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol 28:15–20
  25. Santos Arrontes D, Fernandez Acenero MJ, Garcia Gonzalez JI et al (2008) Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index. J Urol 179:857–861
  26. Hollingsworth JM, Miller DC, Daignault S et al (2007) Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis. Cancer 109:1763–1768
  27. Kutikov A, Egleston BL, Wong YN et al (2010) Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol 28:311–317
  28. Kutikov A, Canter D, Uzzo RG et al (2012) Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. J Urol 188:2077–2083
  29. Smaldone MC, Kutikov A, Egleston BL et al (2012) Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 118:997–1006
  30. Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182:844–853
  31. Ficarra V, Novara G, Secco S et al (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 56(5):786–793
  32. Simmons MN, Ching CB, Samplaski MK et al (2010) Kidney tumor location measurement using the C index method. J Urol 183:1708–1713
  33. Cha E, Jeun B, Casey N et al (2010) Identification of nephrometric variables predictive of renal impairment following partial nephrectomy. J Urol 183:e205
  34. Hayn M, Schwaab T, Underwood W et al (2010) Application of R.E.N.A.L. nephrometry score to laparoscopic partial nephrectomy. J Urol 183:e245
  35. Khemees TA, Yuh BJ, Stacey A et al (2010) Postoperative morbidity of robotic versus open partial nephrectomy: the impact of preoperative tumor characteristics. J Urol 183:e386
  36. Tomaszewski JJ, Smaldone MC, Uzzo RG et al (2014) Anatomic complexity quantitated by nephrometry score is associated with prolonged warm ischemia time during robotic partial nephrectomy. Urology 84:340–344
  37. Hafez KS, Novick AC, Butler BP (1998) Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location. J Urol 159:1156–1160
  38. Kutikov A, Manley BJ, Canter D et al (2010) Anatomical features of enhancing renal masses predict histology and grade–an analysis using nephrometry. J Urol 183(4):e479
  39. Novick AC, Streem S, Montie JE et al (1989) Conservative surgery for renal cell carcinoma: a singlecenter experience with 100 patients. J Urol 141:835–839
  40. Fergany AF, Hafez KS, Novick AC (2000) Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year follow-up. J Urol 163:442–445
  41. Uzzo RG, Novick AC (2001) Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 166:6–18
  42. Thompson RH, Siddiqui S, Lohse CM et al (2009) Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol 182:2601–2606
  43. Dulabon LM, Lowrance WT, Russo P et al (2010) Trends in renal tumor surgery delivery within the United States. Cancer 116:2316–2321
  44. Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047
  45. McKiernan J, Simmons R, Katz J et al (2002) Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59:816–820
  46. Huang WC, Levey AS, Serio AM et al (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7:735–740
  47. Go AS, Chertow GM, Fan D et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305
  48. Letourneau I, Ouimet D, Dumont M et al (2003) Renal replacement in end-stage renal disease patients over 75 years old. Am J Nephrol 23:71–77
  49. Cooperberg MR, Kane CJ, Mallin K et al (2009) National trends in treatment of stage I renal cell carcinoma. J Urol 181:319 (abstract)
  50. Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101:297–301
  51. Giuliani L, Giberti C, Martorana G et al (1990) Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol 143:468–473; discussion 473–474
  52. Weight CJ, Larson BT, Fergany AF et al (2010) Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 183:1317–1323
  53. Thompson RH, Boorjian SA, Lohse CM et al (2008) Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 179:468–471; discussion 472–473
  54. Huang WC, Elkin EB, Levey AS et al (2009) Partial nephrectomy versus radical nephrectomy in patients with small renal tumors–is there a difference in mortality and cardiovascular outcomes? J Urol 181:55–61; discussion 61–62
  55. Lesage K, Joniau S, Fransis K et al (2007) Comparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and healthrelated quality of life. Eur Urol 51:614–620
  56. Uzzo RG, Wei JT, Hafez K et al (1999) Comparison of direct hospital costs and length of stay for radical nephrectomy versus nephron-sparing surgery in the management of localized renal cell carcinoma. Urology 54:994–998
  57. Van Poppel H, Da Pozzo L, Albrecht W et al (2007) A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephronsparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 51:1606–1615
  58. Patard JJ, Pantuck AJ, Crepel M et al (2007) Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur Urol 52:148–154
  59. Hansen J, Sun M, Bianchi M et al (2012) Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy. Urology 80:347–353
  60. Breau RH et al (2010) Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol 183:903–908
  61. Long CA, Canter DJ, Kutikov A et al (2012) Partial nephrectomy for renal masses > 7cm: technical, oncological and functional outcomes. BJU Int 109:1450–1456
  62. Berger A, Brandina R, Atalla MA et al (2009) Laparoscopic radical nephrectomy for renal cell carcinoma: oncological outcomes at 10 years or more. J Urol 182:2172–2176
  63. Tsui KH, Shvarts O, Smith RB et al (2000) Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 163:1090–1095
  64. Permpongkosol S, Chan DY, Link RE et al (2005) Long-term survival analysis after laparoscopic radical nephrectomy. J Urol 174:1222–1225
  65. Colombo JR Jr, Haber GP, Jelovsek JE et al (2008) Seven years after laparoscopic radical nephrectomy: oncologic and renal functional outcomes. Urology 71:1149–1154
  66. Clayman RV, Kavoussi LR, Soper NJ et al (1991) Laparoscopic nephrectomy: initial case report. J Urol 146:278–282
  67. Desai MM, Gill IS, Ramani AP et al (2003) Laparoscopic radical nephrectomy for cancer with level I renal vein involvement. J Urol 169:487–491
  68. Guzzo TJ, Schaeffer EM, McNeil BK et al (2009) Laparoscopic radical nephrectomy for patients with pathologic T3b renal-cell carcinoma: the Johns Hopkins experience. J Endourol 23:63–67
  69. Steinnerd LE, Vardi IY, Bhayani SB (2007) Laparoscopic radical nephrectomy for renal carcinoma with known level I renal vein tumor thrombus. Urology 69:662–665
  70. Gill IS, Kavoussi LR, Lane BR et al (2007) Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 178:41–46
  71. Gill IS, Desai MM, Kaouk JH et al (2002) Laparoscopic partial nephrectomy for renal tumor: duplicating open surgical techniques. J Urol 167:469–7; discussion 475–476
  72. Haber GP, White WM, Crouzet S et al (2010) Robotic versus laparoscopic partial nephrectomy: singlesurgeon matched cohort study of 150 patients. Urology 76:754–758
  73. Wang AJ, Bhayani SB (2009) Robotic partial nephrectomy versus laparoscopic partial nephrectomy for renal cell carcinoma: single-surgeon analysis of >100 consecutive procedures. Urology 73:306–310
  74. Ho H, Schwentner C, Neururer R et al (2009) Roboticassisted laparoscopic partial nephrectomy: surgical technique and clinical outcomes at 1 year. BJU Int 103:663–668
  75. Benway BM, Bhayani SB, Rogers CG et al (2009) Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multiinstitutional analysis of perioperative outcomes. J Urol 182:866–872
  76. Scoll BJ, Uzzo RG, Chen DY et al (2010) Robotassisted partial nephrectomy: a large singleinstitutional experience. Urology 75:1328–1334
  77. Gaur DD, Agarwal DK, Purohit KC (1993) Retroperitoneal laparoscopic nephrectomy: initial case report. J Urol 149:103–105
  78. McAllister M, Bhayani SB, Ong A et al (2004) Vena caval transection during retroperitoneoscopic nephrectomy: report of the complication and review of the literature. J Urol 172:183–185
  79. Viterbo R, Greenberg RE, Al-Saleem T et al (2005) Prior abdominal surgery and radiation do not complicate the retroperitoneoscopic approach to the kidney or adrenal gland. J Urol 174:446–450
  80. Matin SF, Gill IS (2002) Laparoscopic radical nephrectomy: retroperitoneal versus transperitoneal approach. Curr Urol Rep 3:164–171
  81. Chen DY, Uzzo RG (2011) Evaluation and management of the renal mass. Med Clin North Am 95:179–189
  82. Blom JHM, Van Poppel H, Marechal JM et al (2012) Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 55:28–34
  83. Volpe A, Panzarella T, Rendon RA et al (2004) The natural history of incidentally detected small renal masses. Cancer 100:738–745
  84. Hoffmann NE, Bischof JC (2002) The cryobiology of cryosurgical injury. Urology 60:40–49
  85. Aron M, Gill IS (2007) Minimally invasive nephronsparing surgery (MINSS) for renal tumours. Part II: probe ablative therapy. Eur Urol 51:348–357
  86. Kunkle DA, Uzzo RG (2008) Cryoablation or radiofrequency ablation of the small renal mass: a metaanalysis. Cancer 113:2671–2680
  87. Kunkle DA, Egleston BL, Uzzo RG (2008) Excise, ablate or observe: the small renal mass dilemma–a meta-analysis and review. J Urol 179:1227–1233; discussion 1233–1234
  88. Thompson RH, Atwell T, Schmit G et al (2015) Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 67(2): 252–259
  89. Finley DS, Beck S, Box G et al (2008) Percutaneous and laparoscopic cryoablation of small renal masses. J Urol 180:492–498; discussion 498
  90. Long CJ, Kutikov A, Canter DJ et al (2011) Percutaneous vs surgical cryoablation of the small renal mass: is efficacy compromised? BJU Int 107:1376–1380
  91. Mehrazin R, Smaldone MC, Kutikov A et al (2014) Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J Urol 192:659–664
  92. Donat SM, Diaz M, Bishoff JT et al (2013) Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol 190:407–416
  93. Crispen PL, Viterbo R, Fox EB et al (2008) Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer 112:1051–1057
  94. Hollenbeck BK, Taub DA, Miller DC et al (2006) National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 67:254–259

[contact-form-7 id=»5168″ title=»Контактная форма 1″]


Добавить комментарий

Войти с помощью: 

Ваш e-mail не будет опубликован. Обязательные поля помечены *